GSK plc (GSK) has announced a “slightly better than expected” first-half performance, and the shares have responded up to 1755.8p.
A forgotten previously announced spin-off causes a huge panic among even professional investors. Many, many years ago that was me (until my then boss reminded me of the spin-off which explained the halving of a particular share price). So, if - like me - you are a bit of a GSK (GSK) share price fan over the last eighteen months, then chill out.
GlaxoSmithKline (GSK) has announced its first quarter of the year results and that it reconfirms its full-year 2022 guidance. We are well ahead on this share tip where we are also drinking our own medicine so what to do now?
Hello Share Tempters. There are two very big British pharmas you could invest in. A long time ago I chose GlaxoSmithKline (GSK), rather than AstraZeneca (AZN). I sometimes regret that choice as AstraZeneca seems to have been the more dynamic company, including with a Covid vaccine for example. But I would not swap holdings now, as I think things are happening at GSK that could improve its share price.